Cleared Traditional

K911808 - GEMINI OPHTHALMIC SURGERY SYSTEM

K911808 is an FDA 510(k) clearance for GEMINI OPHTHALMIC SURGERY SYSTEM, manufactured by Alcon Laboratories. The device is a Class 2 Ophthalmic device with product code HQC cleared through the Traditional 510(k) pathway after a 63-day FDA review.

K911808 · Alcon Laboratories · Ophthalmic device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 1991
Decision
63d
Days
Class 2
Risk

K911808 is an FDA 510(k) clearance for the GEMINI OPHTHALMIC SURGERY SYSTEM. Classified as Unit, Phacofragmentation (product code HQC), Class II - Special Controls.

Submitted by Alcon Laboratories (Fort Worth, US). The FDA issued a Cleared decision on June 25, 1991 after a review of 63 days - a notably fast clearance cycle.

This device falls under the Ophthalmic FDA review panel, regulated under 21 CFR 886.4670 - the FDA ophthalmic device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Alcon Laboratories devices

FDA 510(k) Submission Details - K911808

510(k) Number K911808 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 23, 1991
Decision Date June 25, 1991
Days to Decision 63 days
Submission Type Traditional
Review Panel Ophthalmic (OP)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
47d faster than avg
Panel avg: 110d · This submission: 63d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

HQC Device Classification - Class 2, Special Controls

Product Code HQC Unit, Phacofragmentation
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 886.4670
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Ophthalmic devices follow this clearance model.

Regulatory Peers - HQC Unit, Phacofragmentation

All 191
Devices cleared under the same product code (HQC) and FDA review panel - the closest regulatory comparables to K911808.
KPE 230 AM
K914172 · Ipax, Inc. · Oct 1991
LOOK VISCODISSECTOR
K913530 · Look, Inc. · Oct 1991
SITE 90 TIP, I/A HANDPIECE .3MM SIDE OPEN/OPTH USE
K912739 · Site Microsurgical Systems, Inc. · Aug 1991
SITE 19 GAUGE ULTRASONIC I/A PHACO NEEDLE
K904151 · Site Microsurgical Systems, Inc. · Dec 1990
SITE PHACOEMULSIFICATION HANDPIECE
K904183 · Site Microsurgical Systems, Inc. · Dec 1990
NIDEK/PHACO EMULSIFICATION SYSTEM MODEL CV-8000
K901686 · Nidek, Inc. · Jun 1990